Viewing Study NCT00772668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-04-08 @ 2:53 PM
Study NCT ID: NCT00772668
Status: TERMINATED
Last Update Posted: 2017-12-11
First Post: 2008-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Sponsor:
Organization: